HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-kun Chen Selected Research

CCT129202

7/2012Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-kun Chen Research Topics

Disease

3Neoplasms (Cancer)
09/2014 - 10/2011
1Breast Neoplasms (Breast Cancer)
09/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2012
1Neoplasm Metastasis (Metastasis)
09/2012
1Esophageal Neoplasms (Esophageal Cancer)
07/2012
1Sarcoma (Soft Tissue Sarcoma)
08/2002

Drug/Important Bio-Agent (IBA)

2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2012 - 08/2002
1multidrug resistance-associated protein 1IBA
09/2014
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2014
1CEP 33779IBA
09/2014
1Janus Kinase 2IBA
09/2014
1Proteins (Proteins, Gene)FDA Link
09/2014
1Aurora KinasesIBA
07/2012
1CCT129202IBA
07/2012
1Adenosine Triphosphate (ATP)IBA
07/2012
1Vincristine (Oncovin)FDA LinkGeneric
07/2012
1Paclitaxel (Taxol)FDA LinkGeneric
07/2012
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2011
1Emodin (Archin)IBA
10/2011
1AnthracyclinesIBA
08/2002
1IfosfamideFDA LinkGeneric
08/2002
1Dacarbazine (DIC)FDA LinkGeneric
08/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
09/2012 - 08/2002
1Therapeutics
09/2014
1Radiotherapy
09/2012
1Salvage Therapy
08/2002